LOS ANGELES, June 25 (Reuters) - Nearly two-thirds of patients who started on weight-loss drugs Wegovy or Zepbound last year were still taking them a year later, according to an analysis of U.S.

The country's immigrant population may have dropped by roughly 2 million people in the first six months of the year, according to new government data. The new data offer an early – if imperfect – ...